Literature DB >> 8315391

Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis.

Z Qin1, S Krüger-Krasagakes, U Kunzendorf, H Hock, T Diamantstein, T Blankenstein.   

Abstract

Tumor necrosis factor (TNF) produced by tumor cells after gene transfer can effectively suppress the growth of locally growing tumors. We wanted to test the effects of "local" TNF on the growth of a highly metastatic cell line. Therefore, a recombinant retrovirus allowing expression of the TNF gene by the beta-actin promotor has been constructed and used to infect the two tumor cell lines EB and ESB, which grow as solid tumor or metastasize, respectively. Expression of TNF by EB cells resulted in their rapid and dose-dependent rejection. In sharp contrast, mice injected with ESB cells producing similar amounts of TNF showed no signs of tumor suppression, but rather had reduced survival rates that correlated with enhanced hepatic metastases. The accelerated formation of liver metastases by ESB TNF cells could be reversed by an anti-TNF mAb. These results demonstrate the opposite effects TNF may have on tumor growth: suppression of a locally growing tumor and promotion of metastasis formation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8315391      PMCID: PMC2191077          DOI: 10.1084/jem.178.1.355

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  Cells secreting tumour necrosis factor show enhanced metastasis in nude mice.

Authors:  S T Malik; M S Naylor; N East; A Oliff; F R Balkwill
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

2.  Tumor cell-endothelial interactions. Increased adhesion of human melanoma cells to activated vascular endothelium.

Authors:  G E Rice; M A Gimbrone; M P Bevilacqua
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

3.  Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice.

Authors:  R Giavazzi; A Garofalo; M R Bani; M Abbate; P Ghezzi; D Boraschi; A Mantovani; E Dejana
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

4.  Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo.

Authors:  B C Guild; M H Finer; D E Housman; R C Mulligan
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

5.  Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin.

Authors:  V M Dixit; S Green; V Sarma; L B Holzman; F W Wolf; K O'Rourke; P A Ward; E V Prochownik; R M Marks
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

6.  Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis.

Authors:  B Echtenacher; W Falk; D N Männel; P H Krammer
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

7.  Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors.

Authors:  A L Asher; J J Mulé; A Kasid; N P Restifo; J C Salo; C M Reichert; G Jaffe; B Fendly; M Kriegler; S A Rosenberg
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

8.  Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.

Authors:  K J Tracey; S Morgello; B Koplin; T J Fahey; J Fox; A Aledo; K R Manogue; A Cerami
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 9.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

10.  Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta.

Authors:  R M Strieter; S L Kunkel; H J Showell; D G Remick; S H Phan; P A Ward; R M Marks
Journal:  Science       Date:  1989-03-17       Impact factor: 47.728

View more
  16 in total

1.  Gambogic acid inhibits TNF-α-induced invasion of human prostate cancer PC3 cells in vitro through PI3K/Akt and NF-κB signaling pathways.

Authors:  Lei Lü; Dong Tang; Liang Wang; Lu-qi Huang; Guo-song Jiang; Xing-yuan Xiao; Fu-qing Zeng
Journal:  Acta Pharmacol Sin       Date:  2012-03-19       Impact factor: 6.150

2.  Tumor necrosis factor-α is associated with positive lymph node status in patients with recurrence of colorectal cancer-indications for anti-TNF-α agents in cancer treatment.

Authors:  M Grimm; M Lazariotou; S Kircher; A Höfelmayr; C T Germer; B H A von Rahden; A M Waaga-Gasser; M Gasser
Journal:  Cell Oncol (Dordr)       Date:  2011-08       Impact factor: 6.730

3.  TNFR2 expression on non-bone marrow-derived cells is crucial for lipopolysaccharide-induced septic shock and downregulation of soluble TNFR2 level in serum.

Authors:  Shubai Liu; Lijie Rong; Jingjing Deng; Xiaopu Zhao; Xiaoman Liu; Xia Xu; Zhihai Qin
Journal:  Cell Mol Immunol       Date:  2011-01-24       Impact factor: 11.530

4.  TNF signaling drives myeloid-derived suppressor cell accumulation.

Authors:  Xueqiang Zhao; Lijie Rong; Xiaopu Zhao; Xiao Li; Xiaoman Liu; Jingjing Deng; Hao Wu; Xia Xu; Ulrike Erben; Peihua Wu; Uta Syrbe; Joachim Sieper; Zhihai Qin
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

5.  Myeloid-derived suppressor cells promote B-cell production of IgA in a TNFR2-dependent manner.

Authors:  Xia Xu; Qinghong Meng; Ulrike Erben; Peigang Wang; Rainer Glauben; Anja A Kühl; Hao Wu; Chung Wah Ma; Minghua Hu; Yuanyuan Wang; Wei Sun; Junying Jia; Xinyi Wu; Wei Chen; Britta Siegmund; Zhihai Qin
Journal:  Cell Mol Immunol       Date:  2016-05-02       Impact factor: 11.530

6.  Ectopic expression of CCL19 impairs alloimmune response in mice.

Authors:  Stefan Krautwald; Ekkehard Ziegler; Reinhold Förster; Lars Ohl; Kerstin Amann; Ulrich Kunzendorf
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

7.  Synergistic antitumor interaction of human monocyte chemotactant protein-1 gene transfer and modulator for tumor-infiltrating macrophages.

Authors:  E Nakashima; Y Kubota; R Matsushita; E Ozaki; F Ichimura; S Kawahara; I Nakanishi; K Kuno; K Matsushima
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

8.  Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha.

Authors:  F M Marincola; S Ettinghausen; P A Cohen; L B Cheshire; N P Restifo; J J Mulé; S A Rosenberg
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

9.  TNFR-1 on tumor cells contributes to the sensitivity of fibrosarcoma to chemotherapy.

Authors:  Jingjing Deng; Xiaopu Zhao; Lijie Rong; Xiao Li; Xiaoman Liu; Zhihai Qin
Journal:  Protein Cell       Date:  2013-04-30       Impact factor: 14.870

10.  The role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control study.

Authors:  Jae Jeong Yang; Kwang-Pil Ko; Lisa Y Cho; Aesun Shin; Jin Gwack; Soung-Hoon Chang; Hai-Rim Shin; Keun-Young Yoo; Daehee Kang; Sue K Park
Journal:  BMC Cancer       Date:  2009-07-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.